Trading Summary - April 11 .
Excellent progress today
Trading Summary - April 11 [significant points in bold].
Excellent progress today for $OTTV despite many top traders being almost fully occupied all day elsewhere.
Top traders were still splitting their time between significant short vs institutional buyer action on $VYST and $HIPH - and reloading $CBDD after its run yesterday - but did find time today to scale in with some more significant ask buys when a new 2019 high was reached and it became obvious that the .2000+ break was imminent.
The main points were:
- 1,352,393 traded - around 2.5 x the 542K traded yesterday.
- The previous .1550 high of 2019 was exceeded by a significant margin - new 2019 high of .1950 was reached.
- Much more ask buying - particularly at .1800 and above.
- Plenty of significant 10K > 85K buys - mostly at the higher prices taking out impatient profit takers undercutting the ask.
- iHub positive posters already stating that they have taken advantage of the averaging down opportunities and are now in the green overall - including their pre-r/s holdings.
- Obviously, those who follow my method for trading successfully through a r/s have been in the green for some time.
- iHub bashers all but disappeared as they were clearly wasting their time and that of everyone else. None of them had any recognized credibility as analysts or traders anyway.
$OTTV achieved 1831% up on the low of just several days ago at the 2019 high of .1950.
Even at the close of .1758 - it was still 1641% up.
Again top OTC traders proved that iHub has been made irrelevant - especially on any board infested with iHub basher / scammers. The "movers and shakers" of the OTC - those with large social media followings above 500 due to their proven record - all network by other means these days and marginalize amateur forums like iHub by declaring #boycottiHub.
Those profiting from $OTTV and discovering how to trade successfully after a r/s are doing just fine and have the shares they need to trade in the small gap between the current price and where individual lots of pre-r/s shares start to go into profit again.
The clueless iHub basher morons keep referring to "averaging down" which isn't what top traders do. They bank huge profits from the bottom up and consider what to do with the higher price pre-r/s inherited lots later - wait for them to go into profit or use to get $6-figure tax bills down in the future - both short term and long term.
As I have stated for the past 7 trading days - and it proved correct again today - anyone who can't make money on $OTTV - by being observant, making correct decisions and ignoring irrelevant factors - shouldn't be trading in the OTC or commenting about the stock.
Viva Entertainment Group, Inc. (OTTV) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....
Continue Reading
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...
Continue Reading
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Latest Position Disclosure by Rathbones Group In the competitive landscape of the financial market, the need for transparency has never been more critical, especially when it comes to securities that hold substantial stakes. Today, we delve into the recent disclosure made by Rathbones Group Plc regarding their position in Primary Health Properties Plc....
Continue Reading
Stride, Inc. Experiences Significant Challenges Recent events have revealed substantial challenges for Stride, Inc. (NYSE: LRN), a company known for its online education platform. Following a significant operational issue stemming from a platform upgrade, the company’s stock has witnessed a dramatic decline, which has drawn the attention of investors and watchdogs...
Continue Reading
MoEngage Recognized as a Customers' Choice for Email Marketing MoEngage, a leader in customer engagement solutions, is thrilled to share its recognition as the only vendor to be named a Customers' Choice in the 2025 Gartner Peer Insights™ Voice of the Customer for Email Marketing report. Achieving an exceptional 97% "Willingness to Recommend" score, MoEngage stands out...
Continue Reading
Class Action Lawsuit Against Organon & Co. Investors may have an opportunity to lead a class action lawsuit against Organon & Co. This follows allegations that the company made misleading statements that adversely affected its stock performance. For those concerned about their investments, this could be a significant moment. Understanding the Class Definition The class...
Continue Reading
NVIDIA's Strategic Options Trading In the world of financial investments, NVIDIA has captured significant attention from market giants through its recent options trading patterns. A thorough analysis of trading activities for NVIDIA (NASDAQ: NVDA) reveals not only an increase in volume but also a notable inclination among traders indicating bullish sentiments....
Continue Reading